|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/00 | |
| C12N 9/52 | |||
| C07K 14/33 |
| (11) | Patento numeris | 2854840 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13714747.6 |
| Europos patento paraiškos padavimo data | 2013-03-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-01-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/030737 |
| Data | 2013-03-13 |
| (87) | Numeris | WO 2013/180799 |
| Data | 2013-12-05 |
| (30) | Numeris | Data | Šalis |
| 201261653214 P | 2012-05-30 | US |
| (72) |
STENMARK, Pål Erik Gustav, SE
BERNTSSON, Ronnie, Per-Arne, SE
DONG, Min, US
PENG, Lisheng, CN
|
| (73) |
President and Fellows of Harvard College,
17 Quincy Street, Cambridge, MA 02138,
US
|
| (54) | ENGINEERED BOTULINUM NEUROTOXIN |
| ENGINEERED BOTULINUM NEUROTOXIN |